← Back to Clinical Trials
Recruiting NCT07076589

NCT07076589 A Comparative Study Between the Usage of Flexible and Navigable Suction Ureteral Access Sheath Versus Traditional Access Sheath in Retrograde Intrarenal Surgeries

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07076589
Status Recruiting
Phase
Sponsor Yosseif elhousseiny ammar ahmed
Condition Stones, Kidney
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2025-06-01
Primary Completion 2026-03-01

Eligibility & Interventions

Sex All sexes
Min Age 14 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
FURS

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2025-06-01 with a primary completion date of 2026-03-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

A comparative study between the Usage of Flexible and Navigable Suction Ureteral Access Sheath (FANS) versus Traditional Access sheath in RIRS : Randomized controlled trial .

Eligibility Criteria

Inclusion Criteria: * Age ≥14 years old in patients not known to have stone forming medical conditions. * Renal stones diameter of ≤2 cm confirmed by CT with all types of configurations (branching \& non-branching). * Non - recurrent cases with no history of previous open renal surgeries or PCNL with normal renal anatomy. * Patients with non - infected urine analysis. Exclusion Criteria: * Patients with abnormal urinary tract anatomy (such as horseshoe kidney or ileal conduit). * Patients with medical conditions promoting stone formation (hyperparathyroidism - gout). * Patients with history of stones on the same side with previous open surgical intervention or PCNL . * Patients with e-GFR \< 60 ml / min. * Patients with uncontrolled urinary tract infection. * Patients with health or other factors that are absolute contraindications to RIRS. * Patients who are unable to understand or complete trial documentation.

Contact & Investigator

Central Contact

Yosseif Ammar, MBBCH

✉ yosefelhousseiny@gmail.com

📞 201226912630

Principal Investigator

Ahmed Yehia Abdelaziz Mohammed, Professor of urology

PRINCIPAL INVESTIGATOR

Cairo University

Frequently Asked Questions

Who can join the NCT07076589 clinical trial?

This trial is open to participants of all sexes, aged 14 Years or older, studying Stones, Kidney. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07076589 currently recruiting?

Yes, NCT07076589 is actively recruiting participants. Contact the research team at yosefelhousseiny@gmail.com for enrollment information.

Where is the NCT07076589 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT07076589 clinical trial?

NCT07076589 is sponsored by Yosseif elhousseiny ammar ahmed. The principal investigator is Ahmed Yehia Abdelaziz Mohammed, Professor of urology at Cairo University. The trial plans to enroll 80 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology